# Efficacy and Safety of Short-term Postoperative Anticoagulant Therapy to Prevente Thrombosis in Arterovenous Fistula

> **NCT04164693** · NA · COMPLETED · sponsor: **First Affiliated Hospital of Chongqing Medical University** · enrollment: 287 (actual)

## Conditions studied

- Thrombosis

## Interventions

- **DRUG:** Low molecular weight heparin
- **OTHER:** non anticoagulant therapy group

## Key facts

- **NCT ID:** NCT04164693
- **Lead sponsor:** First Affiliated Hospital of Chongqing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-09-30
- **Target enrollment:** 287 (ACTUAL)
- **Last updated:** 2024-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04164693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04164693, "Efficacy and Safety of Short-term Postoperative Anticoagulant Therapy to Prevente Thrombosis in Arterovenous Fistula". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT04164693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*